Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Boesenbergia pandurata extract, derived from the tropical plant fingerroot, is a natural product rich in the cyclohexenyl chalcone panduratin A. It exhibits a broad range of biological activities, including anti-inflammatory, antioxidant, antibacterial, and anti-obesity properties. Research has focused on its potential to treat sarcopenia by activating the PI3K/Akt/mTOR pathway and inhibiting proteolysis via FoxO3a. Additionally, it has been investigated for oral health (periodontitis), skin hydration and anti-aging, and certain cancers. While primarily studied as a functional food or nutricosmetic ingredient, its development is largely academic, with significant research conducted at Yonsei University.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on boesenbergia pandurata extract.